Insider Trades Reveal Confidence in Erasca’s RAS/MAPK Oncology Pipeline – What It Means for Investors
Investor insight: Erasca insider trades show confidence in its RAS‑MAPK oncology pipeline, blending ESPP buys, Rule 10b5‑1 plans and option exercise for long‑term value.
4 minutes to read